Skip to main content
Elsevier

Revolutionizing Cancer Treatment

The Power of Molecularly Imprinted Polymers for Precision Therapy

  • 1st Edition - March 24, 2026
  • Latest edition
  • Editors: Bhupendra G. Prajapati, Devesh U. Kapoor, Anand Krishnan, Rishabha Malviya
  • Language: English

Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy examines the transformative role of molecularly imprinted polymers (MIPs) in can… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Explore now

Description

Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy examines the transformative role of molecularly imprinted polymers (MIPs) in cancer management and treatment. This comprehensive book explores how MIPs can be utilized to create advanced drug delivery systems specifically targeting various cancer types, including breast, prostate, and lung cancers, among others. By integrating molecular imprinting techniques with precision oncology, this resource provides valuable insights for researchers, clinicians, and pharmaceutical developers aiming to enhance cancer therapies. Structured in a user-friendly format, the book includes detailed chapters dedicated to specific cancer types, highlighting the design and application of MIPs in targeted therapies.

Users will find flow charts, process diagrams, and case studies to facilitate understanding of complex concepts. The necessity for this book arises from the pressing demand for precision medicine in oncology, as conventional treatments often suffer from issues of specificity and efficacy. Ultimately, this work serves as a vital reference for students, researchers, and healthcare professionals dedicated to advancing cancer treatment through innovative drug delivery systems.

Key features

  • Focuses on a distinct cancer type (e.g., breast, prostate, pancreatic, and lung), detailing how MIPs can be tailored for drug delivery and treatment
  • Provides a solid foundation in the principles and latest advancements of this technology, addressing challenges and opportunities for researchers and industrial professionals seeking to innovate or enhance current therapeutic techniques
  • Emphasizes how MIPs can serve as precision tools in cancer therapy
  • Delves into various molecular imprinting methods used to develop MIP-based drug delivery systems

Readership

Researchers and students in the fields of pharmaceutical sciences, oncology, and biomedical engineering

Table of contents

1. Introduction

2. Molecular imprinting techniques in the development of molecularly imprinted polymers-based drug delivery systems for cancer

3. Targeting Breast Cancer: Innovations with Molecularly Imprinted Polymers.

4. Targeting Prostate Cancer: Innovations with Molecularly Imprinted Polymers.

5. Targeting Pancreatic Cancer: Innovations with Molecularly Imprinted Polymers.

6. Targeting Lung Cancer: Innovations with Molecularly Imprinted Polymers.

7. Targeting Brain Cancer: Innovations with Molecularly Imprinted Polymers.

8. Targeting Ovarian Cancer: Innovations with Molecularly Imprinted Polymers.

9. Targeting Liver Cancer: Innovations with Molecularly Imprinted Polymers.

10. Targeting Cervical Cancer: Innovations with Molecularly Imprinted Polymers.

11. Targeting Colon Cancer: Innovations with Molecularly Imprinted Polymers.

12. Molecularly imprinted polymers as precision tools in cancer

Product details

  • Edition: 1
  • Latest edition
  • Published: March 25, 2026
  • Language: English

About the editors

BP

Bhupendra G. Prajapati

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.

Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India

DK

Devesh U. Kapoor

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.

Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India

AK

Anand Krishnan

Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.

Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

RM

Rishabha Malviya

Rishabha Malviya, did his PhD (Pharmacy) work in the area of novel formulation development techniques. He has 12 years of research experience and presently works as an Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His area of research interest includes formulation optimization, nano formulation, nanorobotic targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical drugs. He has authored more than 200 research/review papers for national/international journals of repute. He has 51 patents and has received an Outstanding Reviewer award from Elsevier. He has authored/edited/editing more than 70 books (Wiley, CRC Press, Springer Nature, River Publishers, De Gryuter, IOP publishing, Nova Science Publishers and Apple Academic Press) and authored 125 book chapters. His name is included in the world's top 2% of scientists in 2020, 2021 and 2022 by Elsevier and Stanford University.

Affiliations and expertise
Galgotias University, India

View book on ScienceDirect

Read Revolutionizing Cancer Treatment on ScienceDirect